Biotech entity

David Garcia

Person

Every one of those 1 sits in a single category, clinical-trial. AI software is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention David Garcia, all published on August 14, 2026.

Last mentioned: Aug 14, 2026

Entity pulse

Recent coverage · David Garcia

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about David Garcia

Every one of those 1 sits in a single category, clinical-trial. AI software is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention David Garcia, all published on August 14, 2026.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 4 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering David Garcia. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Q2 earnings reported

    Nortech Systems, CapsoVision, and Andersen Group publish Q2 2026 earnings call highlights, revealing mixed segment performance and margin dynamics.

  2. Andersen implements rate adjustment

    Andersen Group raises billing rates effective July and has already introduced a 3% tax surcharge for certain client contracts signed beginning in Q2.

  3. Q2 2026 quarter ends

    Nortech net sales reach $33.5M, CapsoVision cumulative patients imaged exceed 176,000, and Andersen first-half revenue totals approximately $458M.

Stories mentioning David Garcia 1

David Garcia is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.